Further pharmacological characterization of eltoprazine: focus on its anxiolytic, anorexic, and adverse-effect potential

Gravius, A; Dekundy, A; Vanaga, A; Franke, L; Danysz, W

Danysz, W (reprint author), Merz Pharmaceut GmbH, Frankfurt, Germany.

ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2017; 77 (1): 77

Abstract

Eltoprazine, a drug that had previously been developed for aggression, has recently been investigated for L-DOPA-induced dyskinesia in animal models o......

Full Text Link